EU cooperation on HTA Flora Giorgio DG SANCO ( eHealth and HTA) Sum - - PowerPoint PPT Presentation

EU cooperation on HTA

EMA-HTA parallel scientific advice Session 1 W hy this is needed and W hat/ W here do w e w ant to get to

Flora Giorgio DG SANCO ( eHealth and HTA)

Sum m ary - EU Cooperation on HTA

• Yesterday
• Today
• Tomorrow

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

2013+

HTA Network

EU cooperation on HTA- How did we get there*

3

2005

Call for project proposals

2009

Call for joint action

2011

Call for joint action

2006-2008

EUnetHTA Project

2009

EUnetHTA Collaboration

2008-2011

Draft Cross Border Healthcare Directive. Article 15 on HTA network

2011-12

CBHC Directive now decided

2013

EU Cooperation

• n HTA

Implementing Decision

2014-2020

Financial support HTA 2011 FP7-Health 2012-Innovation-1 New methodologies for HTA

Legislation DG R&I Health Programme

2010-2012

EUnetHTA JA

2016-2020

EUnetHTA Scientific and technical cooperation Horizon 2020 Calls Health Care

2012-2015

EUnetHTA JA2

* Adapted from slide of Prof. Finn Børlum Kristensen - Thanks

EU Cooperation in HTA - today

• HTA Netw ork (art 15 Directive 2011/ 24)–

strategic level (1st meeting 16 October 2013) MS representatives (mainly MoH); EMA associated

• EUnetHTA (Joint Action HP)– scientific level –
• n-going until October 2015  HTA doers (mainly

HTA Agencies)

• Two levels in synergy and complementary
• Involvement of stakeholders - both @ strategic

level and scientific level

EU cooperation on HTA- results

• EU HTA community built up  more trust

between HTA doers.

• Common HTA methodologies have been produced

 joint piloting are on-going.

• IT tools and training facilities are in place  for

common use and sharing

EU cooperation in HTA – W here do w e w ant to go - HTA Netw ork MW P* ( I )

• Adoption of a long term vision on HTA

cooperation and priorities for next phase of scientific cooperation (JA 3):

• Scope of technologies (pharma, MD, complex

interventions)

• Scope of HTA: clinical versus other domains
• Scope of interventions (from single technologies to

micro/ intermediate/ macro issues)

• Sustainable and cost/ effective cooperation mechanism

* Multiannual Work Programme adopted by the HTA Network on 16 October 2013

EU cooperation in HTA – W here do w e w ant to go - HTA Netw ork MW P ( I I )

• Reflection paper on synergies between HTA and

regulatory process  2nd half 2015

Defragmentation ; cost-effectiveness

• EUnetHTA pilots on early dialogues
• EMA early dialogues
• EC funded tender "SEEDS" 10 pilots on early dialogues

(pharma + MD)

• EMA-EUnetHTA Joint workplan

EU cooperation in HTA – W here do w e w ant to go - HTA Netw ork MW P* ( I I I )

• Reflection paper on conditions to facilitate take

up and re-use at national level of joint HTA production including information and joint assessments 1st half 2015

• Lessons from pilots
• More "pilots" in the next phase of scientific cooperation

Conclusions

• New phase of EU cooperation on HTA
• Increase synergies/ defragmentation
• Share common vision
• Build on achievements

Thank you

flora.giorgio@ec.europa.eu http:/ / ec.europa.eu/ health/ technolog y_ assessm ent/ policy/ index_ en.htm